
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.
When the economy improves and interest rates go up, insurance companies should see earnings improve. He far prefers Sun Life (SLF-T) as MFC-T had to cut dividends during the financial crisis, but SLF-T did not. There are some issues about the guaranteed contracts they sold, leaving speculation that higher liabilities than expected. The dividend is okay and it has started to rise again. It is an okay company
They just changed management from a gentleman that 'steadied the ship'. The new one comes from managing operations in Asia. He expects new management looking at legacy assets that have held the company back. It is one of his primary holdings in the financial group. He thinks they will do well in a rising interest rate environment. They are much more present in Asia than any of the others. It is well capitalized.
It went through its struggles during the financial crisis. They have been one of the more successful companies expanding into Asia. Their ratios are in great shape and earnings are growing in double digits. It has become a well run business once again.